DeHeng Advised Onco Care on Closing Financing of Over RMB 100 Million

2021-09-22

Onco Care Technology (Suzhou) Co., Ltd., an early cancer screening company, recently announced the closing of the latest round of financing with Oriza Seed as the lead investor, followed by Addor Capital. So far, Onco Care has raised over RMB 100 million which will be used to expand the research and development pipeline of cancer gene methylation detection products, multi-center clinical trials, medical device registration applications, and product marketing.

On behalf of Onco Care, the DeHeng team, with primary support from partners Yang Min and Tang Mu, participated in the discussion of the transaction documents, review and revision of the transaction text, and assisted the client in completing the delivery. In particular, DeHeng helped the client formulate a negotiation and cooperation strategy in response to its demands and the investors', and finally completed the signing and delivery of transaction documents, winning high praises from the client.